| 3.1 |
12.3 |
GO:0003360 |
brainstem development(GO:0003360) |
| 2.7 |
10.8 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 2.7 |
8.0 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) |
| 2.5 |
5.0 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 2.5 |
7.4 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 2.5 |
7.4 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 2.4 |
2.4 |
GO:0061642 |
chemoattraction of axon(GO:0061642) |
| 2.1 |
6.4 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 2.1 |
12.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.9 |
9.6 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.9 |
13.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 1.8 |
5.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.8 |
5.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.8 |
7.0 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 1.7 |
5.2 |
GO:0097401 |
synaptic vesicle lumen acidification(GO:0097401) |
| 1.7 |
1.7 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.7 |
18.2 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 1.6 |
4.9 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 1.6 |
6.2 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 1.5 |
7.6 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.5 |
10.5 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.5 |
4.5 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 1.5 |
14.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 1.4 |
9.9 |
GO:0000320 |
re-entry into mitotic cell cycle(GO:0000320) |
| 1.3 |
4.0 |
GO:0060853 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
| 1.3 |
4.0 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.3 |
6.7 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 1.3 |
9.3 |
GO:0044027 |
hypermethylation of CpG island(GO:0044027) |
| 1.3 |
5.3 |
GO:2000705 |
regulation of dense core granule biogenesis(GO:2000705) |
| 1.3 |
4.0 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.3 |
11.5 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 1.3 |
3.8 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.2 |
2.5 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) ganglion morphogenesis(GO:0061552) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) |
| 1.2 |
1.2 |
GO:0061110 |
dense core granule biogenesis(GO:0061110) |
| 1.2 |
3.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 1.2 |
2.4 |
GO:1900133 |
renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 1.2 |
3.7 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 1.2 |
2.4 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.1 |
6.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 1.1 |
8.0 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 1.1 |
4.5 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 1.1 |
3.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 1.1 |
1.1 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 1.1 |
5.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 1.1 |
3.3 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 1.1 |
6.6 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 1.1 |
1.1 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 1.1 |
2.2 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.1 |
2.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.1 |
4.3 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.0 |
3.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 1.0 |
8.2 |
GO:1900107 |
regulation of nodal signaling pathway(GO:1900107) |
| 1.0 |
3.1 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 1.0 |
2.0 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 1.0 |
4.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 1.0 |
3.0 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.0 |
1.0 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 1.0 |
3.0 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 1.0 |
13.6 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.0 |
5.8 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.9 |
5.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.9 |
2.8 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.9 |
3.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.9 |
0.9 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.9 |
9.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.9 |
10.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.9 |
2.7 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.9 |
2.7 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.9 |
6.2 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.9 |
7.1 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.9 |
0.9 |
GO:0035984 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.9 |
9.7 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.8 |
1.7 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.8 |
3.3 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.8 |
9.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.8 |
11.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.8 |
1.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.8 |
1.6 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.8 |
4.0 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.8 |
4.8 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.8 |
1.6 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.8 |
3.9 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.8 |
4.7 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.8 |
2.3 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.8 |
10.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.7 |
0.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 0.7 |
5.2 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.7 |
0.7 |
GO:0033627 |
cell adhesion mediated by integrin(GO:0033627) |
| 0.7 |
3.7 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.7 |
2.2 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.7 |
1.5 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.7 |
0.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.7 |
3.5 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 |
0.7 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.7 |
2.8 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 0.7 |
0.7 |
GO:0090239 |
regulation of histone H4 acetylation(GO:0090239) |
| 0.7 |
13.0 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.7 |
1.4 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.7 |
3.4 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.7 |
4.0 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.7 |
1.3 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.7 |
5.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.7 |
2.0 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 |
2.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
1.3 |
GO:0009988 |
cell-cell recognition(GO:0009988) |
| 0.6 |
1.9 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.6 |
1.9 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.6 |
7.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.6 |
0.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.6 |
7.7 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.6 |
4.4 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.6 |
1.9 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 0.6 |
3.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.6 |
8.1 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.6 |
2.5 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.6 |
8.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.6 |
1.8 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.6 |
0.6 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.6 |
4.2 |
GO:1903423 |
positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.6 |
1.8 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.6 |
1.8 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.6 |
2.4 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
0.6 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.6 |
0.6 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.6 |
2.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.6 |
0.6 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.6 |
1.7 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.6 |
3.5 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.6 |
2.3 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 |
1.7 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.6 |
4.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.6 |
1.1 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.6 |
3.4 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.6 |
0.6 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 |
2.3 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.6 |
2.8 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.6 |
2.3 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 |
0.6 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.6 |
0.6 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) AV node cell to bundle of His cell communication(GO:0086067) |
| 0.6 |
1.7 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.6 |
0.6 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.5 |
1.1 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.5 |
2.7 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
6.5 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.5 |
1.6 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.5 |
3.3 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.5 |
0.5 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 |
2.7 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.5 |
2.6 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.5 |
1.0 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.5 |
2.6 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.5 |
0.5 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.5 |
1.0 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.5 |
1.5 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.5 |
0.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 |
4.6 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.5 |
1.5 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.5 |
0.5 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 0.5 |
2.5 |
GO:0046600 |
negative regulation of centriole replication(GO:0046600) |
| 0.5 |
2.5 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.5 |
3.0 |
GO:0035087 |
siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.5 |
3.5 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.5 |
1.5 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.5 |
1.0 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.5 |
3.0 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 |
4.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
6.4 |
GO:0060065 |
uterus development(GO:0060065) |
| 0.5 |
1.0 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.5 |
2.9 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.5 |
1.0 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.5 |
1.0 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.5 |
1.4 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.5 |
1.4 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.5 |
1.4 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.5 |
0.5 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.5 |
1.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.5 |
1.9 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.5 |
0.5 |
GO:1900044 |
regulation of protein K63-linked ubiquitination(GO:1900044) |
| 0.5 |
1.4 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.5 |
1.9 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.5 |
1.4 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.5 |
4.2 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.5 |
8.0 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.5 |
3.3 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.5 |
1.8 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.5 |
3.7 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.5 |
4.1 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 |
2.3 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.5 |
2.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.4 |
2.2 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.4 |
1.3 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.4 |
1.8 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.4 |
0.4 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.4 |
1.3 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.4 |
0.4 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) |
| 0.4 |
1.7 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 |
0.9 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.4 |
1.3 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.4 |
1.7 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.4 |
1.7 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.4 |
1.7 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.4 |
2.5 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.4 |
0.4 |
GO:0051572 |
negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.4 |
1.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.4 |
0.4 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.4 |
1.2 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.4 |
1.2 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.4 |
2.5 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.4 |
0.4 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.4 |
0.8 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.4 |
2.0 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.4 |
1.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.4 |
1.6 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.4 |
2.0 |
GO:0035022 |
positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.4 |
1.2 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.4 |
0.4 |
GO:0060264 |
respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
| 0.4 |
2.8 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.4 |
2.0 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.4 |
1.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.4 |
1.2 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 |
2.0 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 |
4.7 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
2.3 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.4 |
3.5 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.4 |
1.5 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.4 |
0.4 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.4 |
4.9 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.4 |
1.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.4 |
3.4 |
GO:0035563 |
positive regulation of chromatin binding(GO:0035563) |
| 0.4 |
1.5 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.4 |
1.5 |
GO:0033504 |
floor plate development(GO:0033504) |
| 0.4 |
1.9 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.4 |
1.5 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.4 |
1.1 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.4 |
0.4 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.4 |
2.9 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.4 |
1.8 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.4 |
1.8 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.4 |
1.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
3.2 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.4 |
4.3 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 |
1.1 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 |
1.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.4 |
3.9 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.4 |
4.2 |
GO:0007530 |
sex determination(GO:0007530) |
| 0.4 |
1.4 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.4 |
2.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 |
2.4 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.3 |
0.7 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 0.3 |
3.5 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.3 |
1.0 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.3 |
4.5 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.3 |
2.1 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.3 |
3.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.3 |
1.0 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
5.1 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 |
2.4 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.3 |
6.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.3 |
3.0 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.3 |
1.7 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.3 |
0.7 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.3 |
0.3 |
GO:0042297 |
vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
| 0.3 |
1.7 |
GO:0072610 |
interleukin-12 secretion(GO:0072610) regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 |
3.0 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
1.7 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.3 |
1.0 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
2.3 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.3 |
1.3 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
1.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
1.0 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.3 |
0.3 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.3 |
0.7 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.3 |
2.9 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 |
1.0 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.3 |
0.6 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.3 |
1.0 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
0.6 |
GO:0044413 |
evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.3 |
1.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.3 |
0.3 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.3 |
6.7 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.3 |
1.6 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.3 |
1.9 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.3 |
0.6 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
0.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.3 |
3.5 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.3 |
1.6 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 |
3.5 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.3 |
0.9 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.3 |
2.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 |
0.9 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.3 |
1.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.3 |
2.5 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
0.3 |
GO:0050942 |
positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.3 |
0.9 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.3 |
0.9 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.3 |
1.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
0.3 |
GO:0046668 |
regulation of retinal cell programmed cell death(GO:0046668) |
| 0.3 |
0.6 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.3 |
0.9 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.3 |
0.6 |
GO:0061045 |
negative regulation of wound healing(GO:0061045) |
| 0.3 |
1.5 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.3 |
0.9 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
0.9 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.3 |
0.3 |
GO:1901295 |
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) regulation of heart induction(GO:0090381) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 0.3 |
0.6 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.3 |
0.9 |
GO:0030222 |
eosinophil differentiation(GO:0030222) |
| 0.3 |
1.5 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.3 |
1.2 |
GO:0046476 |
glycosylceramide biosynthetic process(GO:0046476) |
| 0.3 |
1.2 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
3.2 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.3 |
0.9 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.3 |
0.9 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.3 |
0.6 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
0.9 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.3 |
2.0 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.3 |
1.4 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.3 |
0.9 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.3 |
0.6 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.3 |
5.1 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.3 |
0.9 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.3 |
1.4 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.3 |
4.5 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.3 |
2.0 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.3 |
0.3 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.3 |
1.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
2.8 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.3 |
1.7 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.3 |
1.4 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.3 |
3.6 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.3 |
1.7 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.3 |
0.6 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
0.6 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.3 |
1.1 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
0.3 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.3 |
0.8 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
2.2 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.3 |
0.8 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.3 |
0.6 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.3 |
0.3 |
GO:0042790 |
transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
| 0.3 |
0.8 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 |
6.6 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.3 |
0.5 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.3 |
4.1 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.3 |
1.1 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.3 |
1.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.3 |
0.5 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 |
1.6 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 |
0.8 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.3 |
1.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
2.9 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
1.3 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.3 |
0.8 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.3 |
2.4 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
1.8 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.3 |
0.8 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 |
1.1 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.3 |
0.3 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 |
1.0 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.5 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.3 |
0.8 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
1.3 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.3 |
0.8 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 |
2.0 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.3 |
1.0 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.3 |
0.8 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.3 |
0.3 |
GO:1902302 |
regulation of potassium ion export(GO:1902302) |
| 0.3 |
0.8 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 |
1.5 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.3 |
0.5 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.3 |
1.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
1.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 |
6.0 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 |
1.0 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
0.2 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.2 |
0.7 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 0.2 |
0.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
1.2 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
0.7 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
1.2 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.2 |
1.2 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.2 |
1.0 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.2 |
5.8 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.2 |
1.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.2 |
1.0 |
GO:0046016 |
carbon catabolite activation of transcription(GO:0045991) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 |
0.2 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 0.2 |
1.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
3.6 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.2 |
0.5 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.2 |
2.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
0.7 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.2 |
1.4 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.2 |
0.7 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 0.2 |
1.7 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
0.7 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.2 |
3.1 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.2 |
0.5 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.2 |
0.9 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.2 |
0.2 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.2 |
0.2 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.2 |
0.9 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.7 |
GO:0009130 |
pyrimidine nucleoside monophosphate biosynthetic process(GO:0009130) deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.2 |
0.7 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.2 |
0.9 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.2 |
0.9 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.2 |
0.5 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
11.2 |
GO:0035690 |
cellular response to drug(GO:0035690) |
| 0.2 |
0.2 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.2 |
1.4 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.2 |
0.5 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.2 |
1.6 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.2 |
1.1 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.2 |
3.2 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
1.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
0.7 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.2 |
0.7 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
1.8 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 |
1.1 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 |
1.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
2.0 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.2 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.2 |
0.2 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.2 |
1.6 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.2 |
0.7 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.2 |
0.7 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.2 |
0.4 |
GO:1903061 |
regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
| 0.2 |
0.7 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 |
3.8 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
0.7 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.2 |
1.8 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
2.0 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.2 |
0.4 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.2 |
0.9 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 |
1.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
1.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.2 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.2 |
1.1 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 |
3.3 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.2 |
3.0 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.2 |
0.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
1.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.2 |
1.1 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 |
0.6 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.2 |
1.1 |
GO:0060839 |
endothelial cell fate commitment(GO:0060839) |
| 0.2 |
1.7 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
0.6 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.4 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.2 |
0.9 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.2 |
4.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
2.5 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.2 |
1.1 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.2 |
1.7 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.2 |
6.3 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.2 |
0.8 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
1.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
0.6 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.2 |
1.5 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.2 |
4.3 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.2 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
0.4 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.2 |
0.6 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.2 |
1.4 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.2 |
21.0 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.2 |
0.2 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.2 |
0.2 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
0.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
1.2 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.2 |
1.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
0.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
1.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
1.4 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 |
0.6 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.2 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.2 |
1.0 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.2 |
0.8 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.2 |
0.6 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.2 |
0.4 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.2 |
2.7 |
GO:0061615 |
glycolytic process through fructose-6-phosphate(GO:0061615) |
| 0.2 |
0.8 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
6.2 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.2 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.2 |
0.8 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.2 |
0.2 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 |
0.8 |
GO:0042523 |
positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
| 0.2 |
0.6 |
GO:0010511 |
regulation of phosphatidylinositol biosynthetic process(GO:0010511) negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.2 |
0.2 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 |
0.7 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.2 |
0.7 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.2 |
0.2 |
GO:2000832 |
negative regulation of growth hormone secretion(GO:0060125) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
2.8 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
0.9 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.2 |
1.9 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.2 |
0.4 |
GO:0043383 |
negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
| 0.2 |
0.9 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.2 |
0.6 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.2 |
1.8 |
GO:0035510 |
DNA dealkylation(GO:0035510) |
| 0.2 |
0.4 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.2 |
2.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.2 |
2.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.2 |
0.4 |
GO:0040038 |
meiotic cytokinesis(GO:0033206) polar body extrusion after meiotic divisions(GO:0040038) |
| 0.2 |
0.7 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.5 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.9 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.2 |
2.2 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.2 |
1.3 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.2 |
0.4 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
1.4 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
4.1 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 |
0.4 |
GO:0043323 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
0.4 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.2 |
1.6 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
0.2 |
GO:0033962 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.2 |
0.3 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.2 |
0.3 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.2 |
0.2 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.2 |
0.2 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.2 |
0.5 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.2 |
0.2 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.2 |
0.5 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.2 |
0.5 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.2 |
0.2 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
0.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
3.4 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.2 |
0.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.2 |
3.6 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.2 |
0.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) glyoxylate metabolic process(GO:0046487) |
| 0.2 |
2.2 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.2 |
0.2 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.2 |
0.3 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.2 |
0.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.2 |
0.2 |
GO:0036493 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 0.2 |
0.7 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
1.2 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.8 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.2 |
2.0 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.2 |
2.0 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.3 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.2 |
0.5 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 |
0.7 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
0.3 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.2 |
1.0 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
1.1 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 |
6.5 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.2 |
0.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.2 |
0.8 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 |
1.1 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
0.2 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.2 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
1.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.9 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
0.2 |
GO:0090594 |
wound healing involved in inflammatory response(GO:0002246) inflammatory response to wounding(GO:0090594) |
| 0.2 |
0.3 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.2 |
0.5 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.2 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.2 |
0.8 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.2 |
0.6 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
1.1 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.6 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
| 0.2 |
0.3 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.2 |
1.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
1.4 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.2 |
1.8 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.2 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.2 |
1.7 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
0.5 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.2 |
1.2 |
GO:0008088 |
axo-dendritic transport(GO:0008088) |
| 0.1 |
2.1 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.1 |
GO:0060669 |
embryonic placenta morphogenesis(GO:0060669) |
| 0.1 |
0.4 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.1 |
GO:0010872 |
regulation of cholesterol esterification(GO:0010872) positive regulation of cholesterol esterification(GO:0010873) |
| 0.1 |
0.9 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
0.4 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.1 |
3.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.1 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.1 |
0.1 |
GO:0036480 |
neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
| 0.1 |
0.9 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.1 |
2.2 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
0.7 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.4 |
GO:0071107 |
response to parathyroid hormone(GO:0071107) |
| 0.1 |
0.6 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 |
0.7 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.4 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
3.3 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
1.1 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
1.3 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
0.1 |
GO:1905065 |
positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.1 |
0.8 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.6 |
GO:0019740 |
nitrogen utilization(GO:0019740) |
| 0.1 |
0.6 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.1 |
1.0 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 |
0.7 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
1.0 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
0.6 |
GO:2001168 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.1 |
0.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
1.4 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.1 |
0.1 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
0.1 |
GO:0014832 |
urinary bladder smooth muscle contraction(GO:0014832) |
| 0.1 |
0.3 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
0.4 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.1 |
0.4 |
GO:0051452 |
intracellular pH reduction(GO:0051452) |
| 0.1 |
0.5 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.7 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 |
0.8 |
GO:0001996 |
regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) positive regulation of heart rate by epinephrine(GO:0003065) positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
| 0.1 |
0.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
1.8 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 |
0.1 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.1 |
0.5 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
1.3 |
GO:0051900 |
regulation of mitochondrial depolarization(GO:0051900) |
| 0.1 |
0.7 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
1.4 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.1 |
0.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.4 |
GO:0032909 |
transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
| 0.1 |
2.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
0.4 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.7 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.7 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.7 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 |
0.1 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.4 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.1 |
0.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.6 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.1 |
0.4 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.3 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
| 0.1 |
0.3 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 |
2.3 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.5 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.8 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.1 |
1.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 |
0.5 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.8 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.8 |
GO:0072176 |
nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
| 0.1 |
3.1 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.1 |
0.5 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.5 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.4 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
2.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
1.3 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.1 |
1.9 |
GO:0031103 |
axon regeneration(GO:0031103) |
| 0.1 |
0.1 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.1 |
2.0 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.6 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.5 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.1 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.1 |
0.2 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.1 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
0.6 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 |
0.5 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
1.1 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.1 |
0.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.5 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
2.3 |
GO:0048011 |
neurotrophin TRK receptor signaling pathway(GO:0048011) |
| 0.1 |
0.6 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.1 |
0.1 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.1 |
1.0 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 |
0.9 |
GO:1903333 |
regulation of protein folding(GO:1903332) negative regulation of protein folding(GO:1903333) |
| 0.1 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.1 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
1.7 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.1 |
1.1 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 |
0.3 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
1.4 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.1 |
0.7 |
GO:1904357 |
negative regulation of telomere maintenance via telomerase(GO:0032211) negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.1 |
0.8 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
2.2 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.1 |
0.4 |
GO:0098751 |
bone cell development(GO:0098751) |
| 0.1 |
7.9 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
0.5 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.3 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.1 |
GO:0036499 |
PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 |
4.6 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.1 |
0.4 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.1 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.1 |
0.1 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.1 |
0.4 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 |
0.7 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.1 |
0.1 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.1 |
0.3 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
2.2 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.5 |
GO:0032075 |
positive regulation of nuclease activity(GO:0032075) |
| 0.1 |
0.6 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 |
0.1 |
GO:1903319 |
positive regulation of protein maturation(GO:1903319) |
| 0.1 |
0.1 |
GO:0072676 |
lymphocyte migration(GO:0072676) |
| 0.1 |
1.1 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.1 |
0.2 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.1 |
0.6 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.1 |
0.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.1 |
1.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
0.5 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) |
| 0.1 |
0.2 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
1.1 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.1 |
1.1 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
0.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.1 |
0.2 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.1 |
1.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.7 |
GO:0086036 |
regulation of cardiac muscle cell membrane potential(GO:0086036) |
| 0.1 |
0.9 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.4 |
GO:0044090 |
positive regulation of vacuole organization(GO:0044090) |
| 0.1 |
0.3 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 |
0.1 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.1 |
0.3 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.1 |
0.2 |
GO:2001240 |
negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
| 0.1 |
1.0 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.1 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
1.8 |
GO:0045022 |
early endosome to late endosome transport(GO:0045022) |
| 0.1 |
0.5 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 |
0.5 |
GO:0033003 |
regulation of mast cell activation(GO:0033003) |
| 0.1 |
0.8 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.2 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.1 |
0.4 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
1.6 |
GO:0045760 |
positive regulation of action potential(GO:0045760) |
| 0.1 |
0.3 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.1 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.1 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.5 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.2 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.6 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.1 |
0.9 |
GO:0003254 |
regulation of membrane depolarization(GO:0003254) |
| 0.1 |
0.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.1 |
2.2 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 |
0.9 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.4 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.1 |
GO:0051695 |
actin filament uncapping(GO:0051695) |
| 0.1 |
0.8 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.1 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.4 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 |
3.0 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.2 |
GO:2000020 |
positive regulation of male gonad development(GO:2000020) |
| 0.1 |
0.4 |
GO:0010677 |
negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
| 0.1 |
1.0 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.3 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.9 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.1 |
0.2 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
1.6 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
| 0.1 |
0.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.3 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.1 |
0.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.5 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
3.2 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.7 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.1 |
1.4 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.1 |
0.3 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.3 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.1 |
0.3 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
| 0.1 |
0.2 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.1 |
0.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.2 |
GO:0072092 |
ureteric bud invasion(GO:0072092) metanephric renal vesicle formation(GO:0072093) |
| 0.1 |
0.6 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.4 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 |
0.2 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 |
2.2 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.1 |
0.6 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
9.8 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.9 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.2 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.1 |
0.2 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
0.2 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.1 |
0.2 |
GO:0072071 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.1 |
0.7 |
GO:0060384 |
innervation(GO:0060384) |
| 0.1 |
0.4 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.1 |
0.2 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.1 |
0.2 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.1 |
1.6 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 |
0.3 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.5 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.4 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.1 |
0.2 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.5 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 |
0.2 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
3.6 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.9 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.2 |
GO:0030826 |
regulation of cGMP biosynthetic process(GO:0030826) |
| 0.1 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
2.0 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.1 |
0.3 |
GO:0071839 |
apoptotic process in bone marrow(GO:0071839) |
| 0.1 |
0.4 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
1.0 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.4 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 |
1.0 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.1 |
0.3 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.1 |
0.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.1 |
GO:0009162 |
nucleoside monophosphate catabolic process(GO:0009125) deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
1.4 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.1 |
0.9 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.1 |
GO:0070857 |
regulation of bile acid biosynthetic process(GO:0070857) |
| 0.1 |
0.3 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.1 |
0.6 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
0.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 |
0.6 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.1 |
0.4 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 |
0.3 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.6 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
1.6 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
1.1 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 |
0.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.4 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.1 |
0.4 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.1 |
0.1 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.9 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.1 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.1 |
0.1 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.1 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.8 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.1 |
0.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.5 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.1 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.1 |
0.2 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.1 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.3 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.1 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.1 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.1 |
0.1 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.1 |
0.1 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.4 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:0032298 |
positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
| 0.1 |
0.5 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 |
0.2 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.1 |
0.8 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.3 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.1 |
0.1 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.2 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.1 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.2 |
GO:1902950 |
regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.1 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.1 |
0.6 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.5 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.1 |
0.2 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
0.7 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.6 |
GO:0046173 |
polyol biosynthetic process(GO:0046173) |
| 0.1 |
0.1 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.1 |
0.1 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.1 |
0.1 |
GO:0033119 |
negative regulation of RNA splicing(GO:0033119) |
| 0.1 |
0.2 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.6 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.1 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.1 |
GO:0071033 |
nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 0.1 |
0.1 |
GO:0021610 |
facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
| 0.1 |
0.3 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.1 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.1 |
0.1 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
1.1 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.1 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) |
| 0.1 |
0.3 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
0.2 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.4 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.1 |
0.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.2 |
GO:0048669 |
collateral sprouting in absence of injury(GO:0048669) |
| 0.1 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 |
0.2 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.1 |
0.2 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
1.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.2 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.0 |
0.4 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.0 |
0.0 |
GO:0031620 |
fever generation(GO:0001660) regulation of fever generation(GO:0031620) |
| 0.0 |
0.2 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.4 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.0 |
0.2 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.0 |
0.0 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.0 |
0.1 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.0 |
0.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.6 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.2 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.0 |
0.0 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.0 |
1.4 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.1 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.0 |
0.1 |
GO:0016074 |
snoRNA metabolic process(GO:0016074) snoRNA processing(GO:0043144) |
| 0.0 |
0.0 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.2 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.3 |
GO:1903078 |
positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.0 |
0.1 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.2 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 |
0.2 |
GO:1900364 |
regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.0 |
0.2 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.2 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.2 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.0 |
0.1 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 |
0.3 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.0 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.0 |
0.5 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.1 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.0 |
0.4 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.0 |
0.0 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.0 |
0.4 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.0 |
0.0 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 |
0.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.0 |
0.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.3 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.0 |
0.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.2 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.0 |
0.2 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.0 |
1.1 |
GO:0006418 |
tRNA aminoacylation for protein translation(GO:0006418) |
| 0.0 |
0.2 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.0 |
GO:0070257 |
regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) regulation of mucus secretion(GO:0070255) positive regulation of mucus secretion(GO:0070257) |
| 0.0 |
0.1 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.0 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.0 |
0.2 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.0 |
0.1 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.0 |
0.3 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.1 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.0 |
0.2 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.0 |
1.8 |
GO:0000086 |
G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.0 |
0.1 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.2 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.8 |
GO:0031398 |
positive regulation of protein ubiquitination(GO:0031398) |
| 0.0 |
0.0 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.2 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 |
1.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.0 |
0.1 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.0 |
0.3 |
GO:0009209 |
pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) |
| 0.0 |
2.0 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.6 |
GO:0000154 |
rRNA modification(GO:0000154) |
| 0.0 |
1.4 |
GO:0045814 |
negative regulation of gene expression, epigenetic(GO:0045814) |
| 0.0 |
0.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.0 |
0.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.0 |
GO:2000834 |
androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.0 |
0.5 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.3 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.0 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.0 |
GO:0016553 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
| 0.0 |
0.2 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.2 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.2 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.0 |
0.1 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.0 |
0.1 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.1 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.0 |
0.2 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.4 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.0 |
0.4 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.0 |
0.1 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 |
0.1 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.1 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.0 |
0.1 |
GO:0090273 |
somatostatin secretion(GO:0070253) regulation of somatostatin secretion(GO:0090273) |
| 0.0 |
1.7 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.2 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.1 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:0009071 |
threonine metabolic process(GO:0006566) serine family amino acid catabolic process(GO:0009071) |
| 0.0 |
0.0 |
GO:0016246 |
RNA interference(GO:0016246) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.2 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.9 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.3 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 |
0.6 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.0 |
0.2 |
GO:0071166 |
ribonucleoprotein complex localization(GO:0071166) |
| 0.0 |
0.0 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.0 |
0.2 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
1.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
0.1 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.1 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.0 |
0.1 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.0 |
0.1 |
GO:0032310 |
prostaglandin secretion(GO:0032310) |
| 0.0 |
0.0 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.0 |
0.1 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.0 |
0.1 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.0 |
0.1 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.0 |
0.4 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.0 |
0.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.1 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.0 |
0.0 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.0 |
0.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.3 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.0 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 |
0.3 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.2 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.2 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
0.7 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.0 |
0.1 |
GO:0090314 |
positive regulation of protein targeting to membrane(GO:0090314) |
| 0.0 |
0.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.0 |
0.0 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.0 |
1.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.0 |
0.3 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.0 |
0.1 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.1 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.0 |
0.0 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.0 |
0.4 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.0 |
0.1 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.2 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
0.0 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 |
0.1 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.0 |
0.2 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.0 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.0 |
0.5 |
GO:0045727 |
positive regulation of translation(GO:0045727) |
| 0.0 |
0.1 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.0 |
0.0 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.0 |
0.1 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.0 |
0.4 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.1 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.0 |
0.0 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.0 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.0 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.0 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.0 |
0.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.0 |
0.0 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.0 |
0.0 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 |
0.0 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.0 |
0.0 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.1 |
GO:0061436 |
establishment of skin barrier(GO:0061436) |
| 0.0 |
0.0 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.0 |
0.0 |
GO:0032988 |
ribonucleoprotein complex disassembly(GO:0032988) |
| 0.0 |
0.1 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 |
0.0 |
GO:0042637 |
catagen(GO:0042637) |
| 0.0 |
0.0 |
GO:0009451 |
RNA modification(GO:0009451) |
| 0.0 |
0.0 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.0 |
0.0 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 0.0 |
0.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.0 |
0.0 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.0 |
0.2 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.0 |
0.0 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.0 |
0.0 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.0 |
0.0 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.0 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
